A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemiaJACKSON, Robert C; RADIVOYEVITCH, Tomas.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 765-776, issn 0344-5704, 12 p.Article

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumorsWAKUI, Hiroshi; YAMAMOTO, Noboru; AKINAGA, Shiro et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 15-23, issn 0344-5704, 9 p.Article

A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignanciesWANG-GILLAM, Andrea; THAKKAR, Nilay; XUNTIAN JIANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 419-426, issn 0344-5704, 8 p.Article

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumorsMCREE, Autumn J; DAVIES, Janine M; SANOFF, Hanna G et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 117-123, issn 0344-5704, 7 p.Article

A phase I trial of flavopiridol in relapsed multiple myelomaHOFMEISTER, Craig C; MING POI; LIN, Thomas S et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 249-257, issn 0344-5704, 9 p.Article

A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic functionSLINGERLAND, Marije; HESS, Dagmar; GELDERBLOM, Hans et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 1089-1098, issn 0344-5704, 10 p.Article

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTereSOARES, Heloisa P; BAYRAKTAR, Soley; WALKER, Gail et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 839-845, issn 0344-5704, 7 p.Article

A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancerHEE MAN KIM; KYONG JOO LEE; JIHYE CHA et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 861-865, issn 0344-5704, 5 p.Article

Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen failsWEIHENG HU; JIAN FANG; JUN NIE et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1129-1136, issn 0344-5704, 8 p.Article

Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastasesKODAMA, Tatsushi; HASEGAWA, Masami; TAKANASHI, Kenji et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 1023-1028, issn 0344-5704, 6 p.Article

Asparaginase in the treatment of non-ALL hematologic malignanciesEMADI, Ashkan; ZOKAEE, Hania; SAUSVILLE, Edward A et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 875-883, issn 0344-5704, 9 p.Article

CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activityBURNS, K. E; GOLDTHORPE, M. A; PORTEUS, F et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 3, pp 651-655, issn 0344-5704, 5 p.Article

Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expressionZHUO WANG; LIJUAN MA; XUEBIN WANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 239-247, issn 0344-5704, 9 p.Article

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinibKALYKAKI, Antonia; AGELAKI, Sofia; KALLERGI, Galatea et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 685-693, issn 0344-5704, 9 p.Article

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)KANG, Yoon-Koo; JEONG HWAN YOOK; YOUNG SOO PARK et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 139-149, issn 0344-5704, 11 p.Article

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experienceKATO, Yuka; HOTTA, Katsuyuki; SHINKAI, Tetsu et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 943-950, issn 0344-5704, 8 p.Article

Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinomaTHIERY-VUILLEMIN, A; MOUILLET, G; PIVOT, X et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 999-1007, issn 0344-5704, 9 p.Article

Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancerTAS, Faruk; KARABULUT, Senem; SERILMEZ, Murat et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 3, pp 631-637, issn 0344-5704, 7 p.Article

Intraperitoneal paclitaxel induces regression of peritoneal metastasis partly by destruction of peripheral microvesselsKITAYAMA, Joji; EMOTO, Shigenobu; YAMAGUCHI, Hironori et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 3, pp 605-612, issn 0344-5704, 8 p.Article

Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progressionMAFFEZZINI, Massimo; CAMPODONICO, Fabio; CANEPA, Giorgio et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 925-930, issn 0344-5704, 6 p.Article

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinomaMOTZER, Robert J; HUTSON, Thomas E; HUDES, Gary R et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 739-750, issn 0344-5704, 12 p.Article

Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?JI YUN LEE; SUNG HEE LIM; JIN SEOK AHN et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 1063-1070, issn 0344-5704, 8 p.Article

KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinomaYUN ZHENG; GERY, Sigal; HAIBO SUN et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 3, pp 487-495, issn 0344-5704, 9 p.Article

Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patientsSLUSARZ, Katherine M; MERKER, Vanessa L; MUZIKANSKY, Alona et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1197-1204, issn 0344-5704, 8 p.Article

Mechanisms of action of tasquinimod on the tumour microenvironmentRAYMOND, E; DALGLEISH, A; DAMBER, J.-E et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 1-8, issn 0344-5704, 8 p.Article